Image of the Day: Regenerating Worms

Planarian flatworms grow to double their normal size when scientists inhibit a gene that suppresses growth.

Written byAmy Schleunes
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: A flatworm whose “degrowing” phase was suppressed towers over a control worm
NORTHWESTERN UNIVERSITY

Repressing a gene in planarian flatworms (Schmidtea mediterranea) that prevents stem cells from producing a key growth factor results in the animals doubling in size, report the authors of a study published on January 20 in Current Biology.

The flatworms are known for their extraordinary ability to regenerate themselves after almost every kind of injury, a process that involves a growing phase followed by a “degrowing” phase during which the worm is scaled back to restore its proportionality. It was the rescaling phase that the researchers blocked in the study.

“These worms have essentially discovered a natural form of regenerative medicine through their evolution,” says Christian Petersen, who studies regeneration at Northwestern University and is coauthor of the paper, in a university press release. “Planarians can regenerate their whole lives, but how do they limit their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies